SMTL ID : 8era.1

RMC-5552 in complex with mTORC1 and FKBP12

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x XZ9: 1-[6-{[(3M)-4-amino-3-(2-amino-1,3-benzoxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl}-3,4-dihydroisoquinolin-2(1H)-yl]-3-hydroxypropan-1-one(Non-covalent)

XZ9.1: 9 residues within 4Å: Chain A: S.2165, K.2187, E.2190, Y.2225, I.2237, G.2238, W.2239, V.2240, I.2356 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:Y.2225, A:I.2237, A:I.2356 Hydrogen bonds: A:S.2165, A:K.2187, A:E.2190, A:G.2238, A:V.2240 pi-Stacking: A:W.2239

1 x XYU: (3S,5R,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30R,34aS)-5,9,27-trihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-5,6,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-octadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,11,28,29(4H,31H)-tetrone(Non-covalent)

XYU.2: 15 residues within 4Å: Chain A: L.2031, S.2035, T.2098, Y.2105, F.2108 Chain B: Y.27, F.37, D.38, F.47, Q.54, E.55, V.56, I.57, Y.83, H.88 6 PLIP interactions: 2 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:Y.2105, A:F.2108, B:F.47, B:V.56 Hydrogen bonds: B:E.55, B:I.57

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Burnett, G.L. et al., Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors. J.Med.Chem. (2023)

Release Date

2022-12-28

Peptides

Serine/threonine-protein kinase mTOR: A
Peptidyl-prolyl cis-trans isomerase FKBP1A: B
Target of rapamycin complex subunit LST8: C
Regulatory-associated protein of mTOR: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
Y

Serine/threonine-protein kinase mTOR

Peptidyl-prolyl cis-trans isomerase FKBP1A

Target of rapamycin complex subunit LST8

Regulatory-associated protein of mTOR

Related Entries With Identical Sequence